Earnings call transcript: HealthEquity Q4 2026 beats EPS & revenue forecasts

HealthEquity beat Q4 FY2026 consensus with EPS $0.95 vs $0.90 (5.56% surprise) and revenue $334.6M vs $331.93M (0.8% surprise), while gross margin expanded to 68% (+700+ bps) and adjusted EBITDA rose 23% to $132.9M. Management raised FY2027 guidance to revenue $1.405–1.415B, non-GAAP EPS $4.56–4.65 and adjusted EBITDA $618–628M, returned >$300M in buybacks in FY2026, and highlighted AI/digital initiatives and forward rate locks (≈$2.4B notional at 3.92%) to de-risk custodial yields. Key operational metrics: 17.8M total accounts, >$36B HSA assets; principal risks include macro headwinds, leverage (~$957M debt), regulatory shifts and competitive pressure.

Analysis

HealthEquity’s results are best read as a platform inflection rather than a one-off beat: management has begun converting scale into durable operating leverage via automation, digital engagement and targeted product expansion. If app-driven interactions can displace a material share of current phone-based service volume over 12–24 months, service costs per account could decline meaningfully and convert modest revenue growth into outsized EBITDA expansion — think incremental margin compression relief rather than pure top-line dependency.

Second-order beneficiaries extend beyond HQY. Network processors capture a recurring lift as more HSA dollars flow through cards and merchant integrations; asset managers and RIA platforms pick up long-duration AUM tailwinds as invested HSA balances mature; conversely, legacy custodial banks that monetize short-duration deposits face structural margin pressure as institutional customers demand better integrated, higher-yield placements and as forward-rate hedging reduces volatility in custodial yields.

Key risks are concentrated and timing-sensitive. A meaningful move lower in interest rates over the next 6–18 months would gradually depress custodial yield income (slowly, by cohort/maturity), a regulatory reversal or tightened HSA rules would compress long-term TAM growth, and marketplace monetization depends on sustained multi-quarter retention of program cohorts. Management’s hedging reduces quarter-to-quarter yield volatility, but it also caps upside if rates re-accelerate — so the earnings optionality is asymmetric and contingent on execution of AI/digital initiatives.

Key Decisions for Investors

• Long HQY equity (12–18 month horizon): overweight the stock to capture continued margin expansion and retail/ACA adoption optionality. Position size 2–4% of portfolio, target +30–40% upside over 12 months, hard stop -15% to protect against execution/regulatory setbacks.
• HQY call spread (12-month): buy a 12–14 month call spread to leverage upside while capping premium outlay. Use the spread to target earnings/catalyst windows (next two quarters) with max loss = premium and asymmetrical upside if marketplace and AI cost saves accelerate.
• Pair trade — long HQY / short WFC (6–12 months): express structural custody/disruption theme. Size long:short ~1:0.5 to reflect HQY’s higher beta; thesis wins if consumer-directed flows and interchange growth outpace legacy bank deposit repricing. Hedge: trim if short-term rates decline sharply.
• Hedge/volatility trade: buy a short-dated (3–6 month) protective put on HQY or collar the equity position through upcoming quarters. Rationale: protects against sudden regulatory headlines, fraud incidents, or a rapid rate shock that compresses custodial yields.